Book Value per Share: PepGen (PEPG)
PepGen Inc. (PEPG) maintains a minimal environmental footprint due to the absence of manufacturing plants and the strict control of reagent disposal. A patent for low-cost peptide synthesis to combat dystrophy will ensure high margins. The book value per share demonstrates capital dynamics, where the 1.73 mark records this metric. The development of neuromuscular drugs in the US relies on the EDO platform for precise molecular delivery.
PepGen Inc - analytical breakdowns and key metrics (PEPG)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:pepgen.com, PEPG
Amid intense competition for RNA therapy delivery efficiency, PepGen Inc. (PEPG) is forced to continuously invest in scientific capital to maintain its market position. The net asset value per share reflects the residual value of the company's assets minus liabilities, demonstrating the business's actual asset base regardless of market expectations, which characterizes these securities as a high-risk venture asset.
Competitor analysis for PepGen Inc.
Net Assets per Single Share Biogen Corp|NBIX - Share Book Value|Book Value per Share RGC (Regencell Bioscience)|AXSM (axsome.com) - Book Value of One Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share Praxis Precision Medicines PRAX|Share Book Value anavex.com|CeriBell - Book Value per Share|Net Asset Value per Share PRTA (Prothena Corporation)|Alector (ALEC) - Net Assets per Single Share|Share Book Value Annexon Biosciences Inc. ANNX|Book Value per Share OMER|NGNE - Book Value of One Share|Book Value per Share ACIU|VYGR (Voyager Therapeutics Inc) - Net Asset Value per Share|Net Assets per Single Share Neumora Therapeutics Inc (NMRA)|Equity per Share Scilex Holding Company, Inc. (SCLX)|Tevogen Bio Holdings (TVGN) - Accounting Value per Share|Accounting Value of a Share alphacognition.com (ACOG)|Book Value per Share CGTX|Inhibikase Therapeutics Inc - Net Assets per Share|Cassava (SAVA) - Net Assets per Single Share|ASRT - Equity per Share|COYA (coyatherapeutics.com) - Book Value per Share|Accounting Value per Share Vistagen|OVID: Accounting Value per Share|Net Assets per Share ABOS|CRVO - Net Assets per Single Share|Share Book Value alteritytherapeutics.com (ATHE)|CLNN: Book Value per Share|Jupiter Neurosciences, Inc. - Net Asset Value per Share|Net Assets per Single Share Relmada Therapeutics, Inc.|ANVS - Share Book Value|Book Value per Share GRCE (gracetx.com)|AIFF (Firefly Neuro) - Book Value of One Share|Net Assets per Single Share ANEW Medical (KLTO)|Equity per Share NeuroSense Therapeutics, Ltd.|Reviva Pharmaceuticals Holdings, Inc. - Book Value per Share|Net Asset Value per Share metaviatx.com MTVA|Accounting Value per Share NRXS (NeurAxis, Inc)|Helius Medical Technologies, Inc. - Book Value per Share|Net Assets per Single Share Passage Bio Corp (PASG)|NEUP: Accounting Value of a Share|Net Assets per Single Share NERV|ATHA (Athira Pharma Inc) - Net Asset Value per Share|Net Assets per Single Share Addex Therapeutics, Ltd. ADXN|Share Book Value Alzamend|Cyclerion Therapeutics - Book Value per Share|Net Asset Value per Share PTIX (protagenic.com)|Pasithea Therapeutics Corp. (KTTA) - Net Assets per Single Share|Share Book Value Cortigent Inc CRGT|Book Value per Share ATXI|BCLI - Book Value of One Share|Book Value per Share CARA|CHRO (chromocell.com) - Net Asset Value per Share|Net Assets per Single Share Eliem Therapeutics, Inc. (ELYM)|Equity per Share Intra-Cellular (ITCI)|Longboard Pharma (LBPH) - Accounting Value per Share|Accounting Value of a Share Marinus Pharma (MRNS)|Book Value per Share NKGN|neurobopharma.com - Net Assets per Share|Sage Therapeutics (SAGE) - Net Assets per Single Share|SNPX - Equity per Share|TRVN (Trevena, Inc) - Book Value per Share|Accounting Value per Share Vigil Neuroscience, Inc.|WENA: Accounting Value per Share|Net Assets per Share CERE